https://www.cerberus-ventures.com https://www.cerberus-ventures.com/terms-of-use https://www.cerberus-ventures.com/contact-us https://www.cerberus-ventures.com/focus https://www.cerberus-ventures.com/portfolio https://www.cerberus-ventures.com/perspectives https://www.cerberus-ventures.com/approach https://www.cerberus-ventures.com/people https://www.cerberus-ventures.com/perspectives/ai-biosecurity-company-red-queen-bio-launches https://www.cerberus-ventures.com/perspectives/an-architectural-approach-to-shaping-the-future https://www.cerberus-ventures.com/perspectives/announcing-our-investment-in-nudge-security https://www.cerberus-ventures.com/perspectives/announcing-our-investment-in-virchow-medical https://www.cerberus-ventures.com/perspectives/ansa-biotechnologies-secures-54-4-million-in-series-b-financing-to-redefine-how-scientists-access-synthetic-dna-with-industrys-first-guaranteed-on-time-service https://www.cerberus-ventures.com/perspectives/beyond-success-striving-for-significance https://www.cerberus-ventures.com/perspectives/ces-2026-quick-takes-from-the-floor https://www.cerberus-ventures.com/perspectives/chipstack-is-joining-cadence https://www.cerberus-ventures.com/perspectives/dg-matrix-raises-20-million https://www.cerberus-ventures.com/perspectives/investing-early-in-bold-missions https://www.cerberus-ventures.com/perspectives/lightsynq-acquired-by-ionq https://www.cerberus-ventures.com/perspectives/lightsynq-raises-series-a-led-by-cerberus-ventures https://www.cerberus-ventures.com/perspectives/maybell-quantum-announces-series-a-funding https://www.cerberus-ventures.com/perspectives/maybell-quantum-secures-40-million-series-b https://www.cerberus-ventures.com/perspectives/nudge-security-raises-22-5m-series-a-to-secure-workforce-ai-and-saas https://www.cerberus-ventures.com/perspectives/prismml-launches-worlds-first-1-bit-ai-model-to-redefine-intelligence-at-the-edge https://www.cerberus-ventures.com/perspectives/prismml-steps-out-of-stealth https://www.cerberus-ventures.com/perspectives/red-queen-bio-bringing-ai-into-the-lab https://www.cerberus-ventures.com/perspectives/syntis-bio-announces-first-patient-dosed-in-phase-1-1b-clinical-trial-of-synt-101-in-obesity-and-key-leadership-additions https://www.cerberus-ventures.com/perspectives/syntis-bio-closes-38-million-financing https://www.cerberus-ventures.com/perspectives/the-crystal-ball-what-2025-holds-for-pivotal-sectors https://www.cerberus-ventures.com/perspectives/the-year-ahead-our-2026-outlook https://www.cerberus-ventures.com/perspectives/why-now-is-the-time-to-build-in-techbio https://www.cerberus-ventures.com/portfolio/ansa-biotechnologies https://www.cerberus-ventures.com/portfolio/chipstack https://www.cerberus-ventures.com/portfolio/dg-matrix https://www.cerberus-ventures.com/portfolio/ferveret https://www.cerberus-ventures.com/portfolio/ghostdog-systems https://www.cerberus-ventures.com/portfolio/lightsynq https://www.cerberus-ventures.com/portfolio/maybell-quantum https://www.cerberus-ventures.com/portfolio/nudge-security https://www.cerberus-ventures.com/portfolio/prismml https://www.cerberus-ventures.com/portfolio/red-queen-bio https://www.cerberus-ventures.com/portfolio/roebling https://www.cerberus-ventures.com/portfolio/syntis-bio https://www.cerberus-ventures.com/portfolio/virchow-medical